Artikel: The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Research in pharmaceutical sciences
2022 Band 18, Heft 1, Seite(n) 39–48
Abstract: Background and purpose: The treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant : Experimental approach: The patients with VAP were randomly assigned to experimental (n = 26) and control (n = 29) groups. The first group ... ...
Abstract | Background and purpose: The treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Experimental approach: The patients with VAP were randomly assigned to experimental (n = 26) and control (n = 29) groups. The first group received IV colistin 4.5 MIU every 12 h + levofloxacin 750 mg IV daily, and the second group received IV colistin with the same dose + meropenem 1 g IV every 8 h for 10 days. The clinical (complete response, partial response, or treatment failure) and microbiological responses at the end of the intervention were recorded and compared between the two groups. Findings/results: The complete response rate was higher (n = 7; 35%) and the failure rate was lower (n = 4; 20%) in the experimental group than in the control group (n = 2; 8%, and n = 11; 44%, respectively), but the differences were not statistically significant. Even though the microbiological response rate was higher in the experimental group (n = 14; 70%) than in the control group (n = 12; 48%), the difference was not statistically significant. The mortality rate was 6 (23.10%) and 4 patients (13.8%) in the experimental and control groups, respectively ( Conclusion and implication: The levofloxacin/colistin combination can be considered an alternative regimen to meropenem/colistin in the treatment of VAP caused by CRAB. |
---|---|
Sprache | Englisch |
Erscheinungsdatum | 2022-12-24 |
Erscheinungsland | Iran |
Dokumenttyp | Journal Article |
ZDB-ID | 2400156-9 |
ISSN | 1735-9414 ; 1735-5362 |
ISSN (online) | 1735-9414 |
ISSN | 1735-5362 |
DOI | 10.4103/1735-5362.363594 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.